PathologybioRxivPreprint
Cholangiocarcinoma presents a distinct myeloid-derived suppressor cell signature compared to other hepatobiliary cancers
D. Bayik, A. Lauko, G. A. Roversi…·J. D. Lathia
The paper identifies a distinct myeloid-derived suppressor cell (MDSC) signature in cholangiocarcinoma (CCA) compared to other hepatobiliary cancers, linking MDSC levels to disease outcomes and potential therapeutic targets.
DOI 10.1101/554600